2585-23-1

Basic information

• Product Name: N-Methyl-4-Nitro-Benzamide
• Synonyms: N-Methyl-4-Nitro-Benzamide;Benzamide, N-methyl-p-nitro-;MFCD01211871
• CAS NO: 2585-23-1
• Molecular Formula: C₈H₈N₂O₃
• Molecular Weight: 180.16072
• Mol File: 2585-23-1.mol
• Article Data: 42

Chemical Properties

• Melting Point: 219 °C
• Boiling Point: 382.6 °C at 760 mmHg
• Flash Point: 185.2 °C
• Appearance: /
• Density: 1.272 g/cm³
• Vapor Pressure: 4.65E-06mmHg at 25°C
• Refractive Index: 1.569
• PKA: 13?+-.0.46(Predicted)
• CAS DataBase Reference: N-Methyl-4-Nitro-Benzamide(CAS DataBase Reference)
• NIST Chemistry Reference: N-Methyl-4-Nitro-Benzamide(2585-23-1)
• EPA Substance Registry System: N-Methyl-4-Nitro-Benzamide(2585-23-1)

Safety Data

• Hazardous Substances Data: 2585-23-1(Hazardous Substances Data)

Usage

General Description

N-Methyl-4-Nitro-Benzamide is a chemical compound with the molecular formula C8H8N2O3. It is a yellow crystalline solid that is commonly used as an intermediate in the production of pharmaceuticals and agrochemicals. N-Methyl-4-Nitro-Benzamide is known for its nitro group, which can act as a strong oxidizing agent in certain reactions. N-Methyl-4-Nitro-Benzamide is also used as a reagent in organic synthesis and as a precursor to various other chemicals. It should be handled with care due to its potential reactivity and toxicity.

InChI:InChI=1/C8H8N2O3/c1-9-8(11)6-2-4-7(5-3-6)10(12)13/h2-5H,1H3,(H,9,11)

Upstream product

• 122-04-3 4-nitro-benzoyl chloride 
• 74-89-5 methylamine 
• 108-24-7 acetic anhydride 
• 16089-71-7 N-(p-nitrobenzylidene)methylamine N-oxide 
• 877-80-5 N-methyl-4-nitrobenzylideneamine 
• 1092-52-0 N-(4-methoxyphenyl)-N-methyl-4-nitrobenzamide 
• 7291-01-2 N,N-dimethyl-4-nitrobenzamide 
• 89399-23-5 N-benzyl-N-methyl-4-nitrobenzamide 
• 10342-64-0 p-nitroacetophenone oxime 
• 80-43-3 bis(1-methyl-1-phenylethyl)peroxide 
• 619-80-7 4-nitrobenzamide 
• 586-78-7 para-nitrophenyl bromide 
• 335344-28-0 N‐methoxymethyl‐N‐methylcarbamoyl(trimethyl)silane 
• 512-56-1 trimethyl phosphite 

Downstream Products

• 82791-54-6 6,7-Dimethoxy-2-methyl-1-(4-nitro-phenyl)-2H-isoquinolin-3-one 
• 134814-87-2 Benzoic acid [methyl-(4-nitro-benzoyl)-amino]-methyl ester 
• 59476-41-4 N-Methyl-N,4-dinitrobenzamide 
• 62-23-7 4-nitro-benzoic acid 
• 20743-51-5 1-methyl-5-(4-nitrophenyl)-1H-tetrazole 
• 1439356-98-5 ethyl 6,7,8-trifluoro-1-methyl-4-oxo-2-(4-nitrophenyl)-1,4-dihydroquinoline-3-carboxylate 
• 1144-74-7 4-nitrobenzophenone 
• 1166974-87-3 N-methyl-5-nitro-[1,1'-biphenyl]-2-carboxamide 
• 66124-26-3 N,N'-Dimethyl-4-nitrobenzamidine 
• 66124-29-6 N,N'-Dimethyl-N-(2,4-dinitro)phenyl-(4-nitro)benzamidine 
• 66124-26-3 N,N'-Dimethyl-(4-nitro)benzamidine 
• 24472-11-5 N-Brom-N-methyl-4-nitrobenzamid 
• 68823-17-6 3-methyl-2-(4-nitro-phenyl)-4,6-dioxo-5-phenyl-5,6-dihydro-4H-[1,3]oxazinium betaine 
• 82897-03-8 N-methyl-4-nitro-N-nitrosobenzamide 

Relevant articles and documents

Design, synthesis, and biological evaluation of 2,4-diamino pyrimidine derivatives as potent FAK inhibitors with anti-cancer and anti-angiogenesis activities

A series of 2,4-diamino pyrimidine (DAPY) derivatives were designed, synthesized, and evaluated as inhibitors of focal adhesion kinase (FAK) with antitumor and anti-angiogenesis activities. Most compounds effectively suppressed the enzymatic activities of

2-(4-methanoyl) anilino-4-aminopyrimidine derivatives and application thereof

The invention belongs to the technical field of chemical medicines, and particularly relates to 2-(4-methanoyl) anilino-4-aminopyrimidine derivatives and application thereof. According to the invention, nitryl, carboxyl, cyano and the like are adopted to

4, 6-disubstituted pyridine [3, 2-d] pyrimidine compound as well as preparation and application thereof

The invention belongs to the technical field of medicines. The invention relates to the field of pharmaceutical chemistry, in particular to a 4, 6-disubstituted pyridine [3, 2-d] pyrimidine compound and pharmaceutically acceptable salt thereof, a preparation method of the compound, a pharmaceutical composition taking the compound as an active ingredient, and application of the compound in preparation of an MNK inhibitor and drugs for treating and/or preventing various cancers and/or metabolic diseases. The present invention relates to compounds represented by formulas I, II, III or IV, and pharmaceutically acceptable salts, hydrates, solvates and metabolites thereof, wherein the variables are described in the claims and the description.